News and Insights of 3D Printing and Manufacturing
Researchers from the German Kiel University have developed novel 3D printed ‘spiky-joints’ that provide wrist injury patients with a more flexible form of arm support.
Pandorum Technologies Pvt., a Bangalore-based biotechnology company, has used 3D bioprinted cornea tissue to promote scarless healing of wounds in the eye.
HP, manufacturers of the award-winning Multi Jet Fusion (MJF) 3D printers, and SmileDirectClub, a Nashville-based teledentistry company, have announced a partnership to increase the production of its customized clear aligners at RAPID + TCT.
XJet, an Israeli 3D printer manufacturer, has sold a Carmel 1400 3D printer to Marvel Medtech, a Wisconsin-based medical device manufacturer specializing in cancer treatment.
3D Printing Industry is in Detroit this week to bring our readers all the news from RAPID + TCT. So far we’ve published over 30 articles dedicated to the all the latest in the additive manufacturing ecosystem – with much more to come.
Canadian 3D bioprinting technology company Aspect Biosystems has announced its involvement in a $2.2 million project seeking to find new treatments for cancer. Starting this year, the company will be working with collaborators at two of the world’s largest pharmaceutical companies Merck and GSK, as well as McGill University’s Goodman Cancer Research Centre in Quebec.
The 3D BioFabrication Facility (BFF) bioprinter from nScrypt, a Florida-based 3D printing system manufacturer, and spaceflight equipment developer Techshot is set to launch on the International Space Station (ISS) next month.
Structo, a Singapore based dental 3D printer OEM has partnered with California based digital dentistry company uLab Systems to streamline the production of orthodontic clear aligners.
California-based institutions Transcriptic, a robotic cloud laboratory platform, and 3Scan, a digital 3D tissue model specialist, have announced a merger to form the company Strateos.
Korean biotechnology companies T&R Biofab and SCM Life Science are to collaborate on the R&D of new 3D printed tissue regenerative products. The two companies will focus on marketable cell patch products and new formulations for cell therapy.